Robotic upper-limb rehabilitation after recent (subacute) stroke

Efficacy of Robotic Rehabilitation for Neuro Recovery of the Upper Limb in Subacute Stroke Survivors: An International Multicenter Randomized Controlled Trial

Not applicable Interventional IRCCS San Raffaele Roma · NCT06839482

This trial will test whether adding the Gloreha Sinfonia robotic exoskeleton to usual therapy helps people with recent stroke regain arm and hand movement better than conventional therapy alone.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment130 (estimated)
Ages18 Years to 85 Years
SexAll
SponsorIRCCS San Raffaele Roma Academic / other
Locations21 sites (Elkins Park, Pennsylvania and 20 other locations)
Trial IDNCT06839482 on ClinicalTrials.gov

What this trial studies

This multicenter, randomized controlled trial compares robotic-assisted upper limb therapy using the Gloreha Sinfonia exoskeleton plus conventional rehabilitation to conventional therapy alone in people with subacute post-stroke paresis. Adults within 90 days of ischemic or hemorrhagic stroke with mild-to-moderate upper limb weakness (MRC ≥2) are randomized to the experimental or control group and receive in-person treatment at participating centers. Primary outcome is change in the Fugl-Meyer Assessment motor score for the upper limb measured at baseline, immediately post-treatment, and at 3 months, with secondary measures including muscle strength, range of motion, eye–hand coordination, and manual dexterity. Remote administration of clinical scales is used for follow-up, and standard exclusion criteria include other neurological or musculoskeletal conditions, severe cognitive or language impairment, recent botulinum toxin injection, or open wounds on the limb.

Who should consider this trial

Good fit: Ideal candidates are adults aged 18–90 within 90 days of an ischemic or hemorrhagic stroke who have mild-to-moderate upper limb weakness (MRC ≥2) and can understand and consent to the protocol.

Not a fit: Patients with severe cognitive or language deficits, very weak or flaccid upper limbs (MRC <2), overlapping neurological or musculoskeletal conditions, recent botulinum toxin injections, or unhealed skin lesions are unlikely to benefit from this intervention.

Why it matters

Potential benefit: If successful, the robotic approach could speed and enhance recovery of arm and hand function, improving independence with daily activities.

How similar studies have performed: Previous trials of robotic-assisted upper limb rehabilitation have shown promising but mixed results, with improvements in some motor outcomes but variability across devices and protocols.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Both sexes
* Age 18-90 years
* Paresis of the upper limb following a recent cerebrovascular event (subacute ischemic or hemorrhagic stroke)
* Moderate to mild muscle weakness in the thumb opponens, common finger flexors, and wrist flexors, assessed with complete joint movement in absence of gravity, Medical Research Council Scale (MRC) ≥ 2
* Time from acute event \<90 days
* Ability to understand and sign the study informed consent
* Ability to perform study procedures.

Exclusion Criteria:

* Presence of other overlapping neurological disorders
* Presence of osteoarticular or neuromuscular disorders affecting upper limb mobility
* Severe psychiatric disorders
* Severe cognitive (MMSE ≤ 17) and/or language impairment compromising exercise comprehension
* Botulinum toxin injection in the affected upper limb within the last 60 days or planned during the study and follow-up period
* Open wounds, infections, or unprotected skin lesions on the upper limb
* Severe spasticity of the upper limb (biceps and wrist and finger flexors) (MAS \> 3)
* Inability to adhere to the exercise program due to low compliance
* Participants who have not signed the informed consent for the study

Where this trial is running

Elkins Park, Pennsylvania and 20 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions StrokeUpper LimbHandRehabilitationRobotic- Assisted TherapySubacute phaseActivities of Daily LivingQuality of Life
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.